Hypoxia-induced loss of SRSF2-dependent DNA methylation promotes CTCF-mediated alternative splicing of VEGFA in breast cancer

[1]  U. Schmitz,et al.  CTCF as a regulator of alternative splicing: new tricks for an old player , 2021, Nucleic acids research.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  G. Semenza,et al.  Hypoxia-Induced Suppression of Alternative Splicing of MBD2 Promotes Breast Cancer Metastasis via Activation of FZD1 , 2021, Cancer Research.

[4]  Dihua Yu,et al.  Tumor microenvironment as a therapeutic target in cancer. , 2020, Pharmacology & therapeutics.

[5]  Zhiqiang Meng,et al.  RJunBase: a database of RNA splice junctions in human normal and cancerous tissues , 2020, Nucleic Acids Res..

[6]  S. Shukla,et al.  Hypoxia-induced TGF-β–RBFOX2–ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer , 2020, NAR cancer.

[7]  E. Goloni-Bertollo,et al.  MicroRNAs as regulators of VEGFA and NFE2L2 in cancer. , 2020, Gene.

[8]  L. Cappabianca,et al.  Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer , 2020, Journal of experimental & clinical cancer research : CR.

[9]  D. Lipscombe,et al.  Cell-specific exon methylation and CTCF binding in neurons regulate calcium ion channel splicing and function , 2020, eLife.

[10]  S. Shukla,et al.  Hypoxia-induced changes in intragenic DNA methylation correlate with alternative splicing in breast cancer , 2020, Journal of Biosciences.

[11]  Z. Cai,et al.  Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules , 2019, Cellular and Molecular Life Sciences.

[12]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[13]  Michael Q. Zhang,et al.  Pervasive Chromatin-RNA Binding Protein Interactions Enable RNA-Based Regulation of Transcription , 2019, Cell.

[14]  Dongjie Zhang,et al.  Identification and characterization of differentially expressed miRNAs in HepG2 cells under normoxic and hypoxic conditions , 2019, RSC advances.

[15]  Eric P. Winer,et al.  Breast Cancer Treatment: A Review , 2019, JAMA.

[16]  H. Jin,et al.  Epigenetic regulation of alternative splicing. , 2018, American journal of cancer research.

[17]  S. V. van Heeringen,et al.  Splicing and Chromatin Factors Jointly Regulate Epidermal Differentiation. , 2018, Cell reports.

[18]  HongJun Zhu,et al.  Hypoxia inducible factor‐1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia‐induced angiogenesis in lung cancer , 2018, Journal of cellular biochemistry.

[19]  Magdalena J Koziol,et al.  Bioinformatics challenges and perspectives when studying the effect of epigenetic modifications on alternative splicing , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[20]  P. Carmeliet,et al.  A hypoxia response element in the Vegfa promoter is required for basal Vegfa expression in skin and for optimal granulation tissue formation during wound healing in mice , 2017, PloS one.

[21]  H. Kato,et al.  Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells , 2017, Scientific Reports.

[22]  D. Lindner,et al.  Interplay between miR-574-3p and hnRNP L regulates VEGFA mRNA translation and tumorigenesis , 2017, Nucleic acids research.

[23]  I. Tannock,et al.  Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors , 2016, Neoplasia.

[24]  David Sturgill,et al.  TET‐catalyzed oxidation of intragenic 5‐methylcytosine regulates CTCF‐dependent alternative splicing , 2016, The EMBO journal.

[25]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[26]  Xin Hu,et al.  Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer , 2016, Clinical Cancer Research.

[27]  Abdel Kareem Azab,et al.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.

[28]  G. Ast,et al.  The alternative role of DNA methylation in splicing regulation. , 2015, Trends in genetics : TIG.

[29]  F. Shibasaki,et al.  Hypoxia-Inducible Factor as an Angiogenic Master Switch , 2015, Front. Pediatr..

[30]  Z. Hojati,et al.  New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological Process , 2014, Avicenna journal of medical biotechnology.

[31]  H. Kolb,et al.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. , 2014, Antioxidants & redox signaling.

[32]  J. Oxley,et al.  SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER , 2014, Oncogene.

[33]  Anton J. Enright,et al.  Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia , 2014, Molecular Cancer.

[34]  I. Rogoveanu,et al.  Angiogenesis Factors Involved in the Pathogenesis of Colorectal Cancer , 2013, Current health sciences journal.

[35]  Athina Mavrou,et al.  SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases. , 2012, Biochemical Society transactions.

[36]  E. Goloni-Bertollo,et al.  VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer , 2012, Journal of Cancer Research and Clinical Oncology.

[37]  A. Kornblihtt.  CTCF: from insulators to alternative splicing regulation , 2012, Cell Research.

[38]  G. Semenza,et al.  Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.

[39]  G. Prager,et al.  Angiogenesis in cancer: Anti-VEGF escape mechanisms. , 2011, Translational lung cancer research.

[40]  M. Ladomery,et al.  WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. , 2011, Cancer cell.

[41]  B. Krock,et al.  Hypoxia-induced angiogenesis: good and evil. , 2011, Genes & cancer.

[42]  Maria Carmo-Fonseca,et al.  Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36 , 2011, Nature Structural &Molecular Biology.

[43]  P. Carmeliet,et al.  Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche. , 2011, Blood.

[44]  Hyunmin Kim,et al.  Pre-mRNA splicing is a determinant of histone H3K36 methylation , 2011, Proceedings of the National Academy of Sciences.

[45]  Hua-Lin Zhou,et al.  Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner , 2011, Proceedings of the National Academy of Sciences.

[46]  R. F. Luco,et al.  Epigenetics in Alternative Pre-mRNA Splicing , 2011, Cell.

[47]  Leigh-Ann MacFarlane,et al.  MicroRNA: Biogenesis, Function and Role in Cancer , 2010, Current genomics.

[48]  A. Harris,et al.  Targeting tumour hypoxia in breast cancer. , 2008, European journal of cancer.

[49]  M. Ladomery,et al.  Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors , 2008, Journal of Cell Science.

[50]  J. Pouysségur,et al.  Hypoxia and cancer , 2007, Journal of Molecular Medicine.

[51]  R. Johnson,et al.  Hypoxia: A key regulator of angiogenesis in cancer , 2007, Cancer and Metastasis Reviews.

[52]  George A. Calin,et al.  A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.

[53]  I. Zachary,et al.  The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease , 2005, Genome Biology.

[54]  M. Lerman,et al.  Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.

[55]  D. Black,et al.  MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. , 2007, Genes & development.